Skip to Content

Pharma Mar SA PHMMF

Morningstar Rating
$44.13 +0.85 (1.95%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PHMMF is trading at a 13% discount.
Price
$44.20
Fair Value
$75.28
Uncertainty
High
1-Star Price
$34.30
5-Star Price
$92.14
Economic Moat
Ncgj
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PHMMF is a good fit for your portfolio.

Trading Information

Previous Close Price
$43.28
Day Range
$44.1344.13
52-Week Range
$32.1069.40
Bid/Ask
$34.26 / $38.15
Market Cap
$772.99 Mil
Volume/Avg
626 / 399

Key Statistics

Price/Earnings (Normalized)
29.76
Price/Sales
4.32
Dividend Yield (Trailing)
1.59%
Dividend Yield (Forward)
1.71%
Total Yield
3.03%

Company Profile

Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
515

Comparables

Valuation

Metric
PHMMF
AELIS
GRF
Price/Earnings (Normalized)
29.7650.06
Price/Book Value
3.6010.251.18
Price/Sales
4.3230.291.10
Price/Cash Flow
21.30
Price/Earnings
PHMMF
AELIS
GRF

Financial Strength

Metric
PHMMF
AELIS
GRF
Quick Ratio
2.362.290.72
Current Ratio
3.012.412.48
Interest Coverage
1.94−38.471.28
Quick Ratio
PHMMF
AELIS
GRF

Profitability

Metric
PHMMF
AELIS
GRF
Return on Assets (Normalized)
4.83%−13.75%1.17%
Return on Equity (Normalized)
8.38%−26.44%4.22%
Return on Invested Capital (Normalized)
8.64%−31.64%3.28%
Return on Assets
PHMMF
AELIS
GRF
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRDdyp$548.8 Bil
VRTX
Vertex Pharmaceuticals IncXzpjgv$109.1 Bil
REGN
Regeneron Pharmaceuticals IncBykbhtw$104.1 Bil
MRNA
Moderna IncByjx$33.7 Bil
ARGX
argenx SE ADRWxpz$23.3 Bil
BNTX
BioNTech SE ADRNkry$21.8 Bil
ALNY
Alnylam Pharmaceuticals IncBmycgf$18.5 Bil
BMRN
Biomarin Pharmaceutical IncNfzjr$16.7 Bil
RPRX
Royalty Pharma PLC Class AJjnljg$13.4 Bil
INCY
Incyte CorpBwppfld$13.0 Bil

Sponsor Center